MedTrace Logo

Fructo-oligosaccharides and Irritable Bowel Syndrome

NCT00806104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-01-17

No results posted yet for this study

Summary

Fructo-oligosaccharides are known as prebiotic ingredients to modulate the composition of the intestinal microbiota and particularly to stimulate the growth of Bifidobacteria. Imbalance of the intestinal microbiota such as reduction of Bifidobacteria is implicated in Irritable Bowel Syndrome (IBS). Thus the objective of the study is to evaluate the effect of fructo-oligosaccharides to improve IBS score and to explore which modifications of the microbiota are responsible of this improvement.

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Fructo-oligosaccharides

Dietary supplementation for 4 weeks

DIETARY_SUPPLEMENT

Maltodextrins

Dietary supplementation for 4 weeks

Sponsors & Collaborators

  • Beghin-Meiji

    lead INDUSTRY

Principal Investigators

  • Michel Dapoigny, MD, PhD · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-07-31
Completion
2010-12-31

Countries

  • France
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00806104 on ClinicalTrials.gov